Skip to content
Tenfell
Awarded contract
Published 07 Apr 2021

Epoprostenol Powder and Solvent (pH10.5) for Solution for Infusion Vials

The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’) · United Kingdom

Key facts

Awarded
04 Mar 2021
Contract starts
04 Mar 2021
Contract ends
04 Mar 2023
Procedure
Open procedure (framework)
Buyer type
Health

Awarded to 43 suppliers

SupplierValue
Mercury Pharma Group—
GlaxoSmithKline—
Martindale Pharma—
Mylan—
Dr Reddy's Laboratories (UK) Ltd—
Teva UK Ltd—
Accord Healthcare Ltd—
Ennogen Healthcare Ltd—
Thornton & Ross Ltd—
Chiesi Limited—
Aventis Pharma Ltd Trading As Sanofi—
Napp Pharmaceuticals—
Zentiva Pharma UK Ltd—
Sandoz Ltd—
Selective Supplies Ltd—
Glenmark Pharmaceuticals Europe Ltd—
Aspire Pharma Ltd—
Cipla (EU) Ltd—
Firstline Pharma Ltd—
Colonis Pharma Ltd—
Baxter Healthcare Ltd—
Bowmed Ibisqus Limited—
Consilient Health Ltd—
Crescent Pharma Limited—
Focus Pharmaceuticals Ltd—
Pfizer Ltd—
Ranbaxy (UK) Ltd—
Aguettant Ltd—
Kent Pharmaceuticals Ltd—
Rosemont Pharmaceuticals Ltd—
Wockhardt UK Limited—
Brown & Burk UK Ltd—
Syri Limited (T/A Thame Laboratories)—
Intrapharm Laboratories Ltd—
Galen Ltd—
Morningside Pharmaceuticals Limited—
Norgine Pharmaceuticals Limited—
hameln pharma ltd—
Correvio GmbH—
Torrent Pharma UK Ltd—
Sintetica Ltd—
Synchrony Pharma Ltd—
Organon Pharmaceutical UK Ltd—

Categories (CPV)

Similar open tenders

About The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on TED archive (UK notices before Brexit) (EU open data (Decision 2011/833/EU)). Always read the original notice before responding.